News

LifeArc LAC-TreatMito team members Rubing Shi and Tamara Hill recently attended MitoCon's Second European Winter School in Mitochondrial Biomedicine, held in Northeast Italy.

Vacancy for Clinical Fellow to join the McArdle and Related Disorders Service at the National Hospital for Neurology & Neurosurgery, Queen Square (London).

We're delighted to announce that Professor Henry Houlden (UCL Queen Square Institute of Neurology) has been appointed as one of the first Group Leaders for the Parkinson’s Research Centre.

Professor Schiavo (UCL Queen Square Institute of Neurology) received the 2026 INA Basic Science Lifetime Achievement Award from the President at the bi-annual congress of the society.

The latest Neuromuscular Diseases (NMD) Research Day took place in November 2025, bringing together clinicians, researchers, and partners to strengthen the future of NMD research.

A new motor neurone disease (MND) research prize launched by the MND Association in honour of its late patron and rugby league legend, Rob Burrow CBE, has been awarded to Dr Oscar Wilkins.

Congratulations to Dr Gita Ramdharry who has been awarded a £1.6 million NIHR Advanced Clinical and Practitioner Academic Fellowship

We are excited to advertise a 3-year fully funded PhD studentship in the group of Professor Andrea Cortese. Application deadline: 28 February 2026

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is proud to present the the 2025 Honorary Member Award Professor Mary Reilly (UCL Queen Square Institute of Neurology).

Professor Mary Reilly receives £1 million funding from UK charity to help track progression in a group of rare conditions.

We're delighted to announce the election of Professor Schiavo (Professor of Cellular Neuroscience, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology) to Academia Europaea.

UCL Queen Square Institute of Neurology held its fourth inaugural lecture evening of 2025, on 26th June 2025.

The researchers have been elected Fellows of the Academy of Medical Sciences in recognition of their ground-breaking research and delivery of new benefits to patients.

Results of the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial are published today in The Lancet.

The Charcot-Marie-Tooth Association (CMTA) has announced a $210,000 investment to advance gene discovery and improve diagnostic success for people with Charcot-Marie-Tooth disease